Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R
Front Transplant. 2024; 3:1353803.
PMID: 38993780
PMC: 11235242.
DOI: 10.3389/frtra.2024.1353803.
Gao H, Wang X, Gan H, Li M, Shi J, Guo Y
Heliyon. 2024; 10(10):e31198.
PMID: 38803862
PMC: 11128510.
DOI: 10.1016/j.heliyon.2024.e31198.
Zhang L, Tang X, Fan C, Ren S, Cheng Q, Zhou H
Biomolecules. 2024; 14(4).
PMID: 38672421
PMC: 11047922.
DOI: 10.3390/biom14040403.
Kim H, Jeong D, Kim J, Chung D
Immune Netw. 2024; 24(1):e6.
PMID: 38455467
PMC: 10917574.
DOI: 10.4110/in.2024.24.e6.
Colomb F, Ogunkanbi A, Jamwal A, Dong B, Maizels R, Finney C
Infect Immun. 2024; 92(3):e0039523.
PMID: 38294241
PMC: 10929406.
DOI: 10.1128/iai.00395-23.
Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis.
Kumar V, Hertz M, Agro A, Byrne A
Front Immunol. 2023; 14:1260503.
PMID: 37818376
PMC: 10561218.
DOI: 10.3389/fimmu.2023.1260503.
The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33.
Palumbo A, Atzeni F, Murdaca G, Gangemi S
Int J Mol Sci. 2023; 24(15).
PMID: 37569519
PMC: 10418664.
DOI: 10.3390/ijms241512143.
Development of Adaptive Immunity and Its Role in Lung Remodeling.
Esnault S, Jarjour N
Adv Exp Med Biol. 2023; 1426:287-351.
PMID: 37464127
DOI: 10.1007/978-3-031-32259-4_14.
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction.
England E, Rees D, Scott I, Carmen S, Chan D, Chaillan Huntington C
Sci Rep. 2023; 13(1):9825.
PMID: 37330528
PMC: 10276851.
DOI: 10.1038/s41598-023-36642-y.
Early activation and recruitment of invariant natural killer T cells during liver ischemia-reperfusion: the major role of the alarmin interleukin-33.
Robin A, Mackowiak C, Bost R, Dujardin F, Barbarin A, Thierry A
Front Immunol. 2023; 14:1099529.
PMID: 37228593
PMC: 10203422.
DOI: 10.3389/fimmu.2023.1099529.
The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses.
Yang X, Tian Y, Zheng L, Luu T, Kwak-Kim J
Int J Mol Sci. 2023; 24(1).
PMID: 36613575
PMC: 9820098.
DOI: 10.3390/ijms24010132.
Association of Soluble ST2 With Functional Outcome, Perihematomal Edema, and Immune Response After Intraparenchymal Hemorrhage.
Bevers M, Booraem C, Li K, Sreekrishnan A, Sastre C, Falcone G
Neurology. 2022; 100(13):e1329-e1338.
PMID: 36549913
PMC: 10065211.
DOI: 10.1212/WNL.0000000000206764.
IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine.
Furci F, Murdaca G, Allegra A, Gammeri L, Senna G, Gangemi S
Int J Mol Sci. 2022; 23(23).
PMID: 36498859
PMC: 9740753.
DOI: 10.3390/ijms232314532.
Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases.
Chen J, Xiao P, Song D, Song D, Chen Z, Li H
Front Cardiovasc Med. 2022; 9:1007450.
PMID: 36407452
PMC: 9671940.
DOI: 10.3389/fcvm.2022.1007450.
Interleukin-33 and Soluble ST2 as Potential Biomarkers of Cancer in Opium Users: A Nested Case-Control Study.
Firouzabadi N, Javdani K, Dehshahri A
Iran J Med Sci. 2022; 47(6):541-548.
PMID: 36380972
PMC: 9652501.
DOI: 10.30476/IJMS.2021.92335.2360.
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases.
Wu E, Zhu J, Ma Z, Tuo B, Terai S, Mizuno K
Front Immunol. 2022; 13:1008047.
PMID: 36275647
PMC: 9583272.
DOI: 10.3389/fimmu.2022.1008047.
Innate lymphoid cells in early tumor development.
Warner K, Ghaedi M, Chung D, Jacquelot N, Ohashi P
Front Immunol. 2022; 13:948358.
PMID: 36032129
PMC: 9411809.
DOI: 10.3389/fimmu.2022.948358.
ILC2s expanded by exogenous IL-33 regulate CD45+CD11b+F4/80high macrophage polarization to alleviate hepatic ischemia-reperfusion injury.
Zhang H, Chen X, Li S, Zhang J, Sun J, Zhou L
Front Immunol. 2022; 13:869365.
PMID: 35967407
PMC: 9372719.
DOI: 10.3389/fimmu.2022.869365.
The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
Lei S, Jin J, Zhao X, Zhou L, Qi G, Yang J
Exp Biol Med (Maywood). 2022; 247(20):1810-1818.
PMID: 35733343
PMC: 9679353.
DOI: 10.1177/15353702221102094.
Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver-resident NK cells.
Imaoka Y, Sato K, Ohira M, Imaoka K, Yano T, Nakano R
Hepatol Commun. 2022; 6(9):2551-2564.
PMID: 35726345
PMC: 9426399.
DOI: 10.1002/hep4.2017.